Identification of possible biomarkers for breast cancer from free fatty acid profiles determined by GC–MS and multivariate statistical analysis

Benson, 2009, Early breast cancer, Lancet, 373, 1463, 10.1016/S0140-6736(09)60316-0 Ely, 2007, Breast cancer overview, Plast Surg Nurs, 27, 128, 10.1097/01.PSN.0000290281.48197.ae Claudino, 2007, Metabolomics: available results, current research projects in breast cancer and future applications, J Clin Oncol, 25, 2840, 10.1200/JCO.2006.09.7550 Wikoff, 2007, Metabolomics identifies perturbations in human disorders of propionate metabolism, Clin Chem, 53, 2169, 10.1373/clinchem.2007.089011 Xue, 2008, A serum metabolomic investigation on hepatocellular carcinoma patients by chemical derivatization followed by gas chromatography/mass spectrometry, Mass Spectrom, 22, 3061 Bogdanov, 2008, Metabolomic profiling to develop blood biomarkers for Parkinson's disease, Brain, 131, 389, 10.1093/brain/awm304 Nicholson, 2002, Metabonomics: a platform for studying drug toxicity and gene function, Nat Rev Drug Discov, 1, 153, 10.1038/nrd728 Jonsson, 2004, A strategy for identifying differences in large series of metabolomic samples analyzed by GC/MS, Anal Chem, 76, 1738, 10.1021/ac0352427 Jonsson, 2005, Highthroughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses, Anal Chem, 77, 5635, 10.1021/ac050601e Deng, 2004, Determination of acetone in human breath by gas chromatography–mass spectrometry and solid-phase microextraction with on-fiber derivatization, J Chromatogr B, 810, 269, 10.1016/S1570-0232(04)00657-9 Yang, 2004, Discrimination of diabetic patients from healthy controls by using metabonomics method based on their serum fatty acid profiles, J Chromatogr B, 813, 53, 10.1016/j.jchromb.2004.09.023 Liu, 2010, Free fatty acid metabolic profile and biomarkers of isolated post-challenge diabetes and type 2 diabetes mellitus based on GC–MS and multivariate statistical analysis, J Chromatogr B, 878, 2817, 10.1016/j.jchromb.2010.08.035 Nam, 2009, Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification, Bioinformatics, 25, 3151, 10.1093/bioinformatics/btp558 Kim, 2010, Multivariate classification of urine metabolome profiles for breast cancer diagnosis, Bioinformatics, 11, S4 Bathen, 2007, MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status, Breast Cancer Res Treat, 104, 181, 10.1007/s10549-006-9400-z Vatten, 1993, Polyunsaturated fatty acids in serum phospholipids and risk of breast cancer: a case–control study from the Janus serum bank in Norway, Eur J Cancer, 29, 532, 10.1016/S0959-8049(05)80146-7 Punnonen, 1989, Phospholipids and fatty acids in breast cancer tissue, J Cancer Res Clin Oncol, 115, 575, 10.1007/BF00391361 Singletary, 2002, Revision of the American Joint Committee on cancer staging system for breast cancer, J Clin Oncol, 20, 3628, 10.1200/JCO.2002.02.026 Barker, 2003, Partial least squares for discrimination, J Chemom, 17, 166, 10.1002/cem.785 Eriksson, 2001 Pohjanen, 2006, Statistical multivariate metabolite profiling for aiding biomarker pattern detection and mechanistic interpretations in GC/MS based metabolomics, Metabolomics, 2, 257, 10.1007/s11306-006-0032-4 Hastie, 2009 Eriksson L, Johansson E, Kettanah-Wold N, Wold S. Umetrics AB, Malmo, Sweden. 1999. User's Guide to SIMCA-P, SIMCA-P+ version 11.0, Umetrics AB, Ume, 2000. Molina, 1995, Use of serial carcinoembryonic antigen and CA15. 3 assays in detecting relapses in breast cancer patients, Breast Cancer Res Treat, 36, 41, 10.1007/BF00690183 Ballesta, 1995, Carcinoembryonic antigen in staging and follow-up of patients with solid tumors, Tumour Biol, 16, 32, 10.1159/000217926 Nicolini, 1999, The role of tumour markers in predicting skeletal metastases in breast cancer patients with equivocal bone scintigraphy, Br J Cancer, 79, 1443, 10.1038/sj.bjc.6690230 Berruti, 1994, Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease, Eur J Cancer, 30A, 2082, 10.1016/0959-8049(94)00356-A Staessena, 1997, Consumption of fatty acids in Belgium and its relationship with cancer mortality, Cancer Lett, 114, 109, 10.1016/S0304-3835(97)04638-7 Howe, 1990, Dietary factors and risk of breast cancer; combined analysis of 12 case control studies, J Natl Cancer Inst, 82, 561, 10.1093/jnci/82.7.561 Murff, 2011, Dietary polyunsaturated fatty acids and breast cancer risk in Chinese women: a prospective cohort study, Int J Cancer, 128, 1434, 10.1002/ijc.25703 Greenwald, 1999, Role of dietary fat in the causation of breast cancer: point, Cancer Epidemiol Biomarkers Prev, 8, 3 Nkondjock, 2003, A case–control study of breast cancer and dietary intake of individual fatty acids and antioxidants in Montreal, Canada, Breast, 12, 131, 10.1016/S0960-9776(02)00284-9 Dhaval, 2008, Significance of alterations in plasma lipid profile levels in breast cancer, Integr Cancer Ther, 7, 33, 10.1177/1534735407313883 Ruddock, 2008, Saturated fatty acids inhibit hepatic insulin action by modulating insulin receptor expression and post-receptor signalling, J Biochem, 144, 599, 10.1093/jb/mvn105 Shannon, 2007, Erythrocyte fatty acids and breast cancer risk: a case–control study in Shanghai, China, Am J Clin Nutr, 85, 1090, 10.1093/ajcn/85.4.1090 Kachhap, 2000, Effect of omega-6 polyunsaturated fatty acid (linoleic acid) on BRCA1 gene expression in MCF-7 cell line, Cancer Lett, 154, 115, 10.1016/S0304-3835(00)00371-2 Rose, 1999, Omega-3 fattyacids as cancer chemopreventive agents, Pharmacol Ther, 83, 217, 10.1016/S0163-7258(99)00026-1 Abu-Bedair, 2003, Serum lipids and tissue DNA content in Egyptian female breast cancer patients, Jpn J Clin Oncol, 33, 278, 10.1093/jjco/hyg059 Am, 2000, Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects, Int J Clin Lab Res, 30, 141, 10.1007/s005990070013 Takata, 2009, Association of serum phospholipid fatty acids with breast cancer risk among postmenopausal cigarette smokers, Cancer Causes Control, 20, 497, 10.1007/s10552-009-9314-2